900000000000523009: POSSIBLY EQUIVALENT TO association reference set (foundation metadata concept)

SNOMED CT Concept\SNOMED CT Model Component\Foundation metadata concept (foundation metadata concept)\Reference set\Association type\Historical association reference set (foundation metadata concept)\POSSIBLY EQUIVALENT TO association reference set (foundation metadata concept)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT model component module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module

900000000001150016 POSSIBLY EQUIVALENT TO association reference set (foundation metadata concept) en Fully specified name Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)

900000000001151017 POSSIBLY EQUIVALENT TO association reference set en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
POSSIBLY EQUIVALENT TO association reference set (foundation metadata concept)	Is a	Historical association reference set (foundation metadata concept)	true	Inferred relationship	Some

Members	targetComponentId
Alopecia cicatrisata	Pseudopelade
Alopecia cicatrisata	Scarring alopecia (disorder)
pseudopelade	Scarring alopecia (disorder)
alfablokerende vasodilatator	Product containing alpha adrenergic receptor antagonist (product)
Alpha thalassaemia (& homozygous)	Homozygous alpha thalassemia
Alpha thalassaemia (& homozygous)	Alpha thalassemia (disorder)
syndrom med alfa-talassami og mental retardering	A rare X-linked syndromic intellectual disability characterized by profound developmental delay, facial dysmorphism, genital abnormalities and alpha thalassemia.
syndrom med alfa-talassami og mental retardering	A rare developmental defect during embryogenesis, a contiguous gene deletion syndrome, is a form of alpha-thalassemia characterized by microcytosis, hypochromia, normal hemoglobin (Hb) level or mild anemia, associated with developmental abnormalities.
Alpha-feto protein blood test (& [antenatal])	Alpha-fetoprotein test - antenatal
Alpha-feto protein blood test (& [antenatal])	Alpha-fetoprotein test - antenatal
Alpha-feto protein blood test (& [antenatal])	Alpha-fetoprotein blood test
Alpha-feto protein blood test (& [antenatal])	Alpha-fetoprotein blood test
Alfa-glucosid-hæmmer	Substance with alpha-glucosidase inhibitor mechanism of action (substance)
alfa/beta-lipoproteinæmi	Primary combined hyperlipidaemia
alfa/beta-lipoproteinæmi	Hyperalphalipoproteinemia
Alpha/beta-adrenergic blocking agent	Product containing adrenergic neurone blocker (product)
Alpha/beta-adrenergic blocking agent	Product containing alpha adrenergic receptor antagonist (product)
Alpha/beta-adrenergic blocking agent	Product containing beta adrenergic receptor antagonist (product)
Alphavirus	Alphavirus (organism)
Alphavirus	Arbovirus
Alports syndrom-lignende hereditær nefrit	A rare renal disease characterized by glomerular nephropathy with hematuria progressing to end-stage renal disease (ESRD), frequently associated with sensorineural deafness, and occasionally with ocular anomalies.
Alports syndrom-lignende hereditær nefrit	Hereditary nephritis (disorder)
Alport's syndrome	Thin basement membrane disease
Alport's syndrome	Thin basement membrane disease
Alport's syndrome	Thin basement membrane disease
alprazolam 1 mg/ml koncentrat	Product containing precisely alprazolam 1 milligram/1 milliliter conventional release oral solution (clinical drug)
alprostadil suppositorium a 1000 µg	Product containing precisely alprostadil 1 milligram/1 each conventional release urethral stick (clinical drug)
alprostadil 1000 µg pellet	Product containing precisely alprostadil 1 milligram/1 each conventional release urethral stick (clinical drug)
Alprostadil 10micrograms injection (pdr for recon)	Product containing precisely alprostadil 10 microgram/1 vial powder for conventional release solution for injection (clinical drug)
Alprostadil 10micrograms injection (pdr for recon)	Product containing precisely alprostadil 10 microgram/1 cartridge powder for conventional release solution for injection (clinical drug)
Alprostadil 10micrograms injection (pdr for recon)	Product containing precisely alprostadil 10 microgram/1 cartridge powder for conventional release solution for injection (clinical drug)
Alprostadil 10micrograms injection (pdr for recon)	Product containing precisely alprostadil 10 microgram/1 vial powder for conventional release solution for injection (clinical drug)
alprostadil 10 µg cylinderampul med injektionsvæske, startpakning	Product containing precisely alprostadil 10 microgram/1 cartridge powder for conventional release solution for injection (clinical drug)
alprostadil 10 µg pulver og solvens til injektionsvæske, opløsning, cylinderampul	Product containing precisely alprostadil 10 microgram/1 cartridge powder for conventional release solution for injection (clinical drug)
alprostadil 10 µg pulver og solvens til injektionsvæske, opløsning, hætteglas	Product containing precisely alprostadil 10 microgram/1 vial powder for conventional release solution for injection (clinical drug)
alprostadil suppositorium a 125 µg	Alprostadil 125 microgram urethral stick
alprostadil 125 µg pellet	Alprostadil 125 microgram urethral stick
Alprostadil 20micrograms injection (pdr for recon)	Alprostadil 20 microgram powder for solution for injection vial
Alprostadil 20micrograms injection (pdr for recon)	Product containing precisely alprostadil 20 microgram/1 cartridge powder for conventional release solution for injection (clinical drug)
Alprostadil 20micrograms injection (pdr for recon)	Alprostadil 20 microgram powder for solution for injection vial
alprostadil 20 µg cylinderampul med injektionsvæske, startpakning	Product containing precisely alprostadil 20 microgram/1 cartridge powder for conventional release solution for injection (clinical drug)
alprostadil 20 µg pulver og solvens til injektionsvæske, opløsning, cylinderampul	Product containing precisely alprostadil 20 microgram/1 cartridge powder for conventional release solution for injection (clinical drug)
alprostadil 20 µg pulver og solvens til injektionsvæske, opløsning, hætteglas	Alprostadil 20 microgram powder for solution for injection vial
alprostadil suppositorium a 250 µg	Alprostadil 250 microgram urethral stick
alprostadil 250 µg pellet	Alprostadil 250 microgram urethral stick
alprostadil 40 µg pulver og solvens til injektionsvæske, opløsning, hætteglas	Alprostadil 40 microgram powder for solution for injection vial
alprostadil suppositorium a 500 µg	Product containing precisely alprostadil 500 microgram/1 each conventional release urethral stick (clinical drug)
alprostadil 500 µg pellet	Product containing precisely alprostadil 500 microgram/1 each conventional release urethral stick (clinical drug)
Alprostadil 5mcg/mL powder	Alprostadil 5 microgram powder for solution for injection vial
alprostadil 5 µg pulver og solvens til injektionsvæske, opløsning, hætteglas	Alprostadil 5 microgram powder for solution for injection vial
alteplase 10 mg pulver og solvens til injektionsvæske, opløsning, hætteglas	Alteplase 10 mg powder for solution for injection vial
alteplase 20 mg pulver og solvens til injektionsvæske, opløsning, hætteglas	Product containing precisely alteplase 20 milligram/1 vial powder for conventional release solution for injection (clinical drug)
alteplase 50 mg pulver og solvens til injektionsvæske, opløsning, hætteglas	Product containing precisely alteplase 50 milligram/1 vial powder for conventional release solution for injection (clinical drug)
ændring i ernæring: potentiale for mere end kroppen har behov for	Future nutrient intake that is anticipated, based on observation, experience, or scientific reason, to exceed estimated nutrient requirement, established reference standards, or recommendations based on physiological needs.
ændring i ernæring: potentiale for mere end kroppen har behov for	At increased risk of food intake greater than requirement
ændring i ernæring: potentiale for mere end kroppen har behov for	Future energy intake that is anticipated, based on observation, experience, or scientific reason, to exceed estimated energy expenditure, established reference standards, or recommendations based on physiological needs.
Alteration in parenting	Impaired parenting (finding)
Alteration in parenting	Alteration in parenting (finding)
Ineffective tissue perfusion (specify type)	Ineffective tissue perfusion (finding)
Ineffective tissue perfusion (specify type)	Alteration in tissue perfusion (finding)
Alternating-pressure bed mattress overlay, reusable	Alternating-pressure bed mattress overlay system
Alternating-pressure bed mattress overlay, single-use	Alternating-pressure bed mattress overlay system
Alternating-pressure chair cushion, reusable	Alternating-pressure chair cushion system
Alternating-pressure chair cushion, single-use	Alternating-pressure chair cushion system
Alternative-complement-pathway C3/C5 convertase	Active C3bBbC3b
Alternative-complement-pathway C3/C5 convertase	Active C3bBb
Ødem ved højdesyge	High altitude pulmonary oedema
Ødem ved højdesyge	High altitude cerebral edema
Altitudinal hemianopsia	Altitudinal scotoma
Altitudinal hemianopsia	Altitudinal hemianopia
bivirkning af astringerende middel indeholdende aluminium	Adverse reaction to aluminium and/or aluminium compound
Aluminum chloride 20% roll-on application	Aluminium chloride 200 mg/mL cutaneous solution
aluminiumchlorid 20 % roll-on-opløsning	Aluminium chloride 200 mg/mL cutaneous solution
aluminiumhydroxid + belladonna	Product containing aluminium hydroxide and belladonna alkaloid (medicinal product)
Aluminiumintoksikation	Aluminium and/or aluminium compound poisoning (disorder)
Ostitis alveolaris, ikke nærmere specificeret	Infection of tooth socket (disorder)
Always eating	Always eating
Always eating	Excessive eating
Alysiella-art	Alysiella
Amantadine hydrochloride 50mg/5 mL syrup	Amantadine hydrochloride 10 mg/mL oral solution
amantadinhydrochlorid 50 mg/5 ml syrup	Amantadine hydrochloride 10 mg/mL oral solution
Amantadine hydrochloride 50mg/5mL syrup	Amantadine hydrochloride 10 mg/mL oral solution
Amaranthus palmeri pollen allergen	Amaranthus palmeri pollen
Amazona ochrocephala oratrix	Amazona ochrocephala
Amazona ochrocephala oratrix	Amazona oratrix (organism)
Amazona ochrocephala oratrix	Amazona oratrix subspecies oratrix (organism)
Amblyopia	Amblyopia (disorder)
Amblyopia	Functional amblyopia (disorder)
Amblyopia: [unspecified] or [congenital]	Functional amblyopia (disorder)
Amblyopia: [unspecified] or [congenital]	Amblyopia (disorder)
Ambrosia artemisiifolia pollen allergen	Ambrosia artemisiifolia pollen (substance)
Ambrosia psilostachya pollen allergen	Ambrosia psilostachya pollen
Ambulation and gait training	Gait training procedure
Ambulation and gait training	Ambulation training (procedure)
ambulatorisk træning og gangtræning	Ambulation training (procedure)
ambulatorisk træning og gangtræning	Gait training procedure
Amebiasis	Infection caused by Entamoeba histolytica
Amebiasis	Amebic infection
Amebiasis	Amebic dysentery (disorder)
Amebicide therapeutic role	Antiprotozoal therapeutic role
Amegakaryocytic thrombocytopenia with congenital malformation	Thrombocytopenic purpura

Start Previous Page 65 of 496 Next End

Reference Sets

Reference set descriptor

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
900000000001150016	POSSIBLY EQUIVALENT TO association reference set (foundation metadata concept)	en	Fully specified name	Active	Entire term case sensitive (core metadata concept)	SNOMED CT model component module (core metadata concept)
900000000001151017	POSSIBLY EQUIVALENT TO association reference set	en	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT model component module (core metadata concept)